Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Data
In IND-enabling studies, HSB-1216 remained tightly bound within the Quatramer™ until reaching its tumor target,…
In IND-enabling studies, HSB-1216 remained tightly bound within the Quatramer™ until reaching its tumor target,…
In IND-enabling studies, HSB-1216 remained tightly bound within the Quatramer™ until reaching its tumor target,…
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
MINNEAPOLIS, April 10, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
MINNEAPOLIS, April 10, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
FREMONT, CA, April 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
FREMONT, CA, April 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
BOTHELL, Wash., April 10, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or…
BOTHELL, Wash., April 10, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or…
CARMEL, Ind., April 10, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
CARMEL, Ind., April 10, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
DUBLIN, Ireland, April 10, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
DUBLIN, Ireland, April 10, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
BERKELEY, Calif., April 10, 2023 (GLOBE NEWSWIRE) — Valitor, a biotechnology company engineering better medicines…
BERKELEY, Calif., April 10, 2023 (GLOBE NEWSWIRE) — Valitor, a biotechnology company engineering better medicines…